Classifying Mild Cognitive Impairment from Behavioral Responses in Emotional Arousal and Valence Evaluation Task - AI Approach for Early Dementia Biomarker in Aging Societies

Mild cognitive impairment prediction based on multi-stream convolutional neural networks

BACKGROUND

Mild cognitive impairment (MCI) is the transition stage between the cognitive decline expected in normal aging and more severe cognitive decline such as dementia. The early diagnosis of MCI plays an important role in human healthcare. Current methods of MCI detection include cognitive tests to screen for executive function impairments, possibly followed by neuroimaging tests. However, these methods are expensive and time-consuming. Several studies have demonstrated that MCI and dementia can be detected by machine learning technologies from different modality data. This study proposes a multi-stream convolutional neural network (MCNN) model to predict MCI from face videos.

RESULTS

The total effective data are 48 facial videos from 45 participants, including 35 videos from normal cognitive participants and 13 videos from MCI participants. The videos are divided into several segments. Then, the MCNN captures the latent facial spatial features and facial dynamic features of each segment and classifies the segment as MCI or normal. Finally, the aggregation stage produces the final detection results of the input video. We evaluate 27 MCNN model combinations including three ResNet architectures, three optimizers, and three activation functions. The experimental results showed that the ResNet-50 backbone with Swish activation function and Ranger optimizer produces the best results with an F1-score of 89% at the segment level. However, the ResNet-18 backbone with Swish and Ranger achieves the F1-score of 100% at the participant level.

CONCLUSIONS

This study presents an efficient new method for predicting MCI from facial videos. Studies have shown that MCI can be detected from facial videos, and facial data can be used as a biomarker for MCI. This approach is very promising for developing accurate models for screening MCI through facial data. It demonstrates that automated, non-invasive, and inexpensive MCI screening methods are feasible and do not require highly subjective paper-and-pencil questionnaires. Evaluation of 27 model combinations also found that ResNet-50 with Swish is more stable for different optimizers. Such results provide directions for hyperparameter tuning to further improve MCI predictions.

Applications of Artificial Intelligence in the Neuropsychological Assessment of Dementia: A Systematic Review

In the context of advancing healthcare, the diagnosis and treatment of cognitive disorders, particularly Mild Cognitive Impairment (MCI) and Alzheimer's Disease (AD), pose significant challenges. This review explores Artificial Intelligence (AI) and Machine Learning (ML) in neuropsychological assessment for the early detection and personalized treatment of MCI and AD. The review includes 37 articles that demonstrate that AI could be an useful instrument for optimizing diagnostic procedures, predicting cognitive decline, and outperforming traditional tests. Three main categories of applications are identified: (1) combining neuropsychological assessment with clinical data, (2) optimizing existing test batteries using ML techniques, and (3) employing virtual reality and games to overcome the limitations of traditional tests. Despite advancements, the review highlights a gap in developing tools that simplify the clinician's workflow and underscores the need for explainable AI in healthcare decision making. Future studies should bridge the gap between technical performance measures and practical clinical utility to yield accurate results and facilitate clinicians' roles. The successful integration of AI/ML in predicting dementia onset could reduce global healthcare costs and benefit aging societies.

Mild Cognitive Impairment Detection with Machine Learning and Topological Data Analysis Applied to EEG Time-series in Facial Emotion Oddball Paradigm

We report a novel approach to dementia neurobiomarker development from EEG time series using topological data analysis (TDA) methodology and machine learning (ML) tools in the 'AI for social good' application domain, with possible following application to home-based point of care diagnostics and cognitive intervention monitoring. We propose a new approach to a digital dementia neurobiomarker for early-onset mild cognitive impairment (MCI) prognosis. We report the best median accuracies in a range of upper 85% linear discriminant analysis (LDA), as well above 90% for linear SVM and deep fully connected neural network classifier models in leave-one-out-subject cross-validation, which presents very encouraging results in a binary healthy cognitive aging versus MCI stages using TDA features applied to brainwave time series patterns captured from a four-channel EEG wearable.Clinical relevance- The reported study offers an objective dementia early onset neurobiomarker prospect to replace traditional subjective paper and pencil tests with an application of EEG-wearable-based and topological data analysis machine learning tools in a possibly successive home-based point-of-care environment.

Machine learning approach for early onset dementia neurobiomarker using EEG network topology features

Introduction

Modern neurotechnology research employing state-of-the-art machine learning algorithms within the so-called "AI for social good" domain contributes to improving the well-being of individuals with a disability. Using digital health technologies, home-based self-diagnostics, or cognitive decline managing approaches with neuro-biomarker feedback may be helpful for older adults to remain independent and improve their wellbeing. We report research results on early-onset dementia neuro-biomarkers to scrutinize cognitive-behavioral intervention management and digital non-pharmacological therapies.

Methods

We present an empirical task in the EEG-based passive brain-computer interface application framework to assess working memory decline for forecasting a mild cognitive impairment. The EEG responses are analyzed in a framework of a network neuroscience technique applied to EEG time series for evaluation and to confirm the initial hypothesis of possible ML application modeling mild cognitive impairment prediction.

Results

We report findings from a pilot study group in Poland for a cognitive decline prediction. We utilize two emotional working memory tasks by analyzing EEG responses to facial emotions reproduced in short videos. A reminiscent interior image oddball task is also employed to validate the proposed methodology further.

Discussion

The proposed three experimental tasks in the current pilot study showcase the critical utilization of artificial intelligence for early-onset dementia prognosis in older adults.

The current state of artificial intelligence-augmented digitized neurocognitive screening test

The cognitive screening test is a brief cognitive examination that could be easily performed in a clinical setting. However, one of the main drawbacks of this test was that only a paper-based version was available, which restricts the test to be manually administered and graded by medical personnel at the health centers. The main solution to these problems was to develop a potential remote assessment for screening individuals with cognitive impairment. Currently, multiple studies have been adopting artificial intelligence (AI) technology into these tests, evolving the conventional paper-based neurocognitive test into a digitized AI-assisted neurocognitive test. These studies provided credible evidence of the potential of AI-augmented cognitive screening tests to be better and provided the framework for future studies to further improve the implementation of AI technology in the cognitive screening test. The objective of this review article is to discuss different types of AI used in digitized cognitive screening tests and their advantages and disadvantages.

Dementia Digital Neuro-biomarker Study from Theta-band EEG Fluctuation Analysis in Facial and Emotional Identification Short-term Memory Oddball Paradigm

An efficient machine learning (ML) implementation in the so-called 'AI for social good' domain shall contribute to dementia digital neuro-biomarker development for early-onset prognosis of a possible cognitive decline. We report encouraging initial developments of wearable EEG-derived theta-band fluctuations examination and a successive classification embracing a time-series complexity examination with a multifractal detrended fluctuation analysis (MFDFA) in the face or emotion video-clip identification short-term oddball memory tasks. We also report findings from a thirty-five elderly volunteer pilot study that EEG responses to instructed to ignore (inhibited) oddball paradigm stimulation results in more informative MFDFA features, leading to better machine learning classification results. The reported pilot project showcases vital social assistance of artificial intelligence (AI) application for an early-onset dementia prognosis. Clinical Relevance- This introduces a candidate for an objective digital neuro-biomarker from theta-band EEG recorded by a wearable for a plausible replacement of biased 'paper & pencil' tests for a mild cognitive impairment (MCI) evaluation.

Neurotechnology and AI Approach for Early Dementia Onset Biomarker from EEG in Emotional Stimulus Evaluation Task

We present an efficient utilization of a machine learning (ML) method concentrating on the 'AI for social good' application. We develop a digital dementia biomarker for early-onset dementia forecast. The paper demonstrates encouraging preliminary results of EEG-wearable-based signal analysis and a subsequent classification adopting a signal complexity test of a multifractal detrended fluctuation analysis (MFDFA) in emotional faces working memory training and evaluation tasks. For the digital biomarker of dementia onset detection, we examine shallow- and deep-learning machine learning models. We report the best median accuracies in a range of 90% for random forest and fully connected neural network classifier models in both emotional faces learning and evaluation experimental tasks. In addition, the classifiers are trained in a ten-fold cross-validation regime to discriminate normal versus mild cognitive impairment (MCI) cognition stages using MFDFA patterns from four-channel EEG recordings. Thirty-five volunteer elderly subjects participate in the current study concentrating on simple wearable EEG-based objective dementia biomarker progression. The reported outcomes showcase an essential social benefit of artificial intelligence (AI) employment for early dementia prediction. Furthermore, we improve ML employment for the succeeding application in an uncomplicated and applied EEG-wearable examination.

Older Adult Mild Cognitive Impairment Prediction from Multiscale Entropy EEG Patterns in Reminiscent Interior Image Working Memory Paradigm

We discuss the practical employment of a machine learning (ML) technique within AI for a social good application. We present an application for elderly adult dementia onset prognostication. First, the paper explains our encouraging preliminary study results of EEG responses analysis using a signal complexity measure of multiscale entropy (MSE) in reminiscent interior working memory evaluation tasks. Then, we compare shallow and deep learning machine learning models for a digital biomarker of dementia onset detection. The evaluated machine-learning models succeed in the most reliable median accuracies above 80% using random forest and fully connected neural network classifiers in automatic discrimination of normal cognition versus a mild cognitive impairment (MCI) task. The classifier input features consist of MSE patterns only derived from four dry EEG electrodes. Fifteen elderly subjects voluntarily participate in the reported study focusing on EEG-based objective dementia biomarker advancement. The results showcase the essential social advantages of artificial intelligence (AI) application for the dementia prognosis and advance ML for the subsequent use for simple objective EEG-based examination.Clinical relevance- This manuscript introduces an objective biomarker from EEG recorded by a wearable for a plausible replacement of a mild cognitive impairment (MCI) evaluation using usual biased paper and pencil examinations.

Contribution of Eye-Tracking to Study Cognitive Impairments Among Clinical Populations

In the field of psychology, the merge of decision-theory and neuroscientific methods produces an array of scientifically recognized paradigms. For example, by exploring consumer’s eye-movement behavior, researchers aim to deepen the understanding of how patterns of retinal activation are being meaningfully transformed into visual experiences and connected with specific reactions (e.g., purchase). Notably, eye-movements provide knowledge of one’s homeostatic balance and gatekeep information that shape decisions. Hence, vision science investigates the quality of observed environments determined under various experimental conditions. Moreover, it answers questions on how human process visual stimuli and use gained information for a successful strategy to achieve certain goals. While capturing cognitive states with the support of the eye-trackers progresses at a relatively fast pace in decision-making research, measuring the visual performance of real-life tasks, which require complex cognitive skills, is tentatively translated into clinical experiments. Nevertheless, the potential of the human eye as a highly valuable source of biomarkers has been underlined. In this article, we aim to draw readers attention to decision-making experimental paradigms supported with eye-tracking technology among clinical populations. Such interdisciplinary approach may become an important component that will (i) help in objectively illustrating patient’s models of beliefs and values, (ii) support clinical interventions, and (iii) contribute to health services. It is possible that shortly, eye-movement data from decision-making experiments will grant the scientific community a greater understanding of mechanisms underlining mental states and consumption practices that medical professionals consider as obsessions, disorders or addiction.

A 5-min Cognitive Task With Deep Learning Accurately Detects Early Alzheimer's Disease

Introduction: The goal of this study was to investigate and compare the classification performance of machine learning with behavioral data from standard neuropsychological tests, a cognitive task, or both.

Methods: A neuropsychological battery and a simple 5-min cognitive task were administered to eight individuals with mild cognitive impairment (MCI), eight individuals with mild Alzheimer's disease (AD), and 41 demographically match controls (CN). A fully connected multilayer perceptron (MLP) network and four supervised traditional machine learning algorithms were used.

Results: Traditional machine learning algorithms achieved similar classification performances with neuropsychological or cognitive data. MLP outperformed traditional algorithms with the cognitive data (either alone or together with neuropsychological data), but not neuropsychological data. In particularly, MLP with a combination of summarized scores from neuropsychological tests and the cognitive task achieved ~90% sensitivity and ~90% specificity. Applying the models to an independent dataset, in which the participants were demographically different from the ones in the main dataset, a high specificity was maintained (100%), but the sensitivity was dropped to 66.67%.

Discussion: Deep learning with data from specific cognitive task(s) holds promise for assisting in the early diagnosis of Alzheimer's disease, but future work with a large and diverse sample is necessary to validate and to improve this approach.